1. Home
  2. REFR vs NOTV Comparison

REFR vs NOTV Comparison

Compare REFR & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REFR
  • NOTV
  • Stock Information
  • Founded
  • REFR 1965
  • NOTV 1974
  • Country
  • REFR United States
  • NOTV United States
  • Employees
  • REFR N/A
  • NOTV N/A
  • Industry
  • REFR Multi-Sector Companies
  • NOTV Biotechnology: Pharmaceutical Preparations
  • Sector
  • REFR Miscellaneous
  • NOTV Health Care
  • Exchange
  • REFR Nasdaq
  • NOTV Nasdaq
  • Market Cap
  • REFR 51.8M
  • NOTV 46.7M
  • IPO Year
  • REFR N/A
  • NOTV 1997
  • Fundamental
  • Price
  • REFR $1.79
  • NOTV $1.28
  • Analyst Decision
  • REFR
  • NOTV Strong Buy
  • Analyst Count
  • REFR 0
  • NOTV 1
  • Target Price
  • REFR N/A
  • NOTV $5.00
  • AVG Volume (30 Days)
  • REFR 56.4K
  • NOTV 397.0K
  • Earning Date
  • REFR 11-06-2025
  • NOTV 12-02-2025
  • Dividend Yield
  • REFR N/A
  • NOTV N/A
  • EPS Growth
  • REFR N/A
  • NOTV N/A
  • EPS
  • REFR N/A
  • NOTV N/A
  • Revenue
  • REFR $1,222,239.00
  • NOTV $505,299,000.00
  • Revenue This Year
  • REFR N/A
  • NOTV $5.64
  • Revenue Next Year
  • REFR N/A
  • NOTV $5.16
  • P/E Ratio
  • REFR N/A
  • NOTV N/A
  • Revenue Growth
  • REFR N/A
  • NOTV 0.85
  • 52 Week Low
  • REFR $0.93
  • NOTV $1.15
  • 52 Week High
  • REFR $2.31
  • NOTV $6.48
  • Technical
  • Relative Strength Index (RSI)
  • REFR 61.80
  • NOTV 40.00
  • Support Level
  • REFR $1.40
  • NOTV $1.36
  • Resistance Level
  • REFR $1.94
  • NOTV $1.55
  • Average True Range (ATR)
  • REFR 0.17
  • NOTV 0.12
  • MACD
  • REFR 0.04
  • NOTV 0.01
  • Stochastic Oscillator
  • REFR 66.67
  • NOTV 10.61

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: